University of Virginia

Running trials

• Not yet recruiting

  VergeRx for Smokers Not Ready to Quit

  NCT07693660· University of Virginia· Source

• Not yet recruiting

  Reciprocal Innovation to Optimize Low-Tech Augmentative and Alternative Communication (AAC) for Individuals

  NCT07581483· Indiana University· Source

• Not yet recruiting

  NHLBI SESAME (SEptal Scoring Along Midline Endocardium) Multi-Center Prospective Study Using Improvised Off-Label Devices

  NCT07806149· National Heart, Lung, and Blood Institute (NHLBI)· Source

• Not yet recruiting

  Time-limited Treatment With Avatrombopag Pre- and Post-CAR T-cell Therapy to Prevent Post-CAR T-cell Cytopenias

  NCT07895017· Phase 2· University of Virginia· Source

• Recruiting

  A Clinical Trial of Bomedemstat in Participants With Polycythemia Vera (MK-3543-025).

  NCT07722611· Phase 2/3· Merck Sharp & Dohme LLC· Source

• Recruiting

  A Research Study Investigating Denecimig (Mim8) in Adults With Acquired Haemophilia A

  NCT07830732· Phase 3· Novo Nordisk A/S· Source

• Not yet recruiting

  Post-exercise Blood Pressure With Inorganic Nitrate

  NCT07869472· University of Virginia· Source

• Not yet recruiting

  Evaluating the Impact of Digital Behavioral Interventions to Address Insomnia and Depression in Breast Cancer Survivors Using an Adaptive Design

  NCT07721064· University of Virginia· Source

• Not yet recruiting

  Rethinking Early Airway Clearence Therapies

  NCT07696338· Nicole Hamblett· Source

• Not yet recruiting

  MCE Molecular Imaging for Myocarditis

  NCT07538544· Early phase 1· University of Virginia· Source

• Not yet recruiting

  Feasibility of a Medical-Legal Partnership Model to Connect Coal Miners QuitAid

  NCT07694492· University of Virginia· Source

• Not yet recruiting

  The Effect of Exercise and Tirzepatide on Weight and Health Outcomes (EXER-MED)

  NCT07298915· Phase 3· University of Virginia· Source

• Recruiting

  HCMR Re-Imaging Study

  NCT07054073· Christopher Kramer· Source

• Recruiting

  A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Non-Small Cell Lung Cancer

  NCT07659782· Phase 2· Verastem, Inc.· Source

• Recruiting

  A US Study That Observes How Parkinson's Disease Changes Over Time in Patients Who Still Have Movement Symptoms Despite Taking Parkinson's Medications

  NCT07330258· Bayer· Source

• Recruiting

  Study of AGN-151607-DP to Assess Adverse Events and Change in Disease Activity in Adult Participants With Upper Limb Essential Tremor

  NCT07673107· Phase 2· AbbVie· Source

• Recruiting

  Paclitaxel-Coated Balloon Treatment of Chronic Rhinosinusitis

  NCT07290140· Airiver Medical, Inc.· Source

• Not yet recruiting

  A System to Help With Freezing of Gait in Parkinson's Patients

  NCT07542743· Barron Associates, Inc.· Source

• Recruiting

  HER2 FPBMC in Patients With Metastatic Breast and Prostate Cancer (AM006)

  NCT07441889· Phase 1/2· University of Virginia· Source

• Recruiting

  Study of Denikitug (GS-1811) Given Alone or With Nivolumab or With Chemotherapy in Adults With Advanced Colorectal Cancer

  NCT07527858· Phase 2· Gilead Sciences· Source

• Enrolling by invitation

  Expanding Access to Cognitive Health Biomarker Testing at Home

  NCT07594665· University of Virginia· Source

• Recruiting

  Human Laboratory Study of Apremilast for Alcohol Use Disorder

  NCT07325266· Phase 2· National Institute on Alcohol Abuse and Alcoholism (NIAAA)· Source

• Not yet recruiting

  Multimodality Cardiovascular Imaging for the Translation of Therapies for Vascular Activation After MI

  NCT05880355· Early phase 1· University of Virginia· Source

• Recruiting

  Phase Ib Study of CD33 FPBMC in Patients With MRD+ AML or MDS

  NCT07270978· Phase 1· University of Virginia· Source

• Recruiting

  Velopharyngeal Dysfunction in Head & Neck Cancer Patients, Pilot Study

  NCT07264036· Vanessa Torrecillas· Source

• Recruiting

  Examining Valence-based Effects in Self-Monitoring Feedback Messages

  NCT07292389· University of Virginia· Source

• Recruiting

  Study of Low-Intensity Focused Ultrasound in Combination With Immunotherapy in Newly Diagnosed Unmethylated Glioblastoma

  NCT07343986· Phase 1· University of Virginia· Source

• Recruiting

  A Study to Investigate Mibavademab in Adult Women With Functional Hypothalamic Amenorrhea

  NCT07235917· Phase 2· Regeneron Pharmaceuticals· Source

• Recruiting

  Impact of Obesity on Microvascular Insulin Action and Cardiorespiratory Fitness in Type 1 Diabetes

  NCT07573228· University of Virginia· Source

• Recruiting

  Evaluation of a Novel Insulin Sensitizer in People With Type 1 Diabetes

  NCT07186660· Phase 2· University of Virginia· Source

• Recruiting

  Stereotactic MRI-guided Focused Ultrasound Mesencephalotomy

  NCT07405645· University of Virginia· Source

• Recruiting

  A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes (BARICADE-PRESERVE)

  NCT07222332· Phase 3· Eli Lilly and Company· Source

• Recruiting

  INHALE-1st: Afrezza® For Youth With Newly-Diagnosed Type 1 Diabetes

  NCT07224321· Phase 2· Mannkind Corporation· Source

• Recruiting

  A Study of Baricitinib (LY3009104) for the Delay of Stage 3 Type 1 Diabetes in At-Risk Children and Adults

  NCT07222137· Phase 3· Eli Lilly and Company· Source

• Recruiting

  Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

  NCT07222566· Phase 3· Pfizer· Source

• Recruiting

  Inorganic Nitrate as a Treatment for ANOCA: NO-ANOCA

  NCT06948201· University of Virginia· Source

• Not yet recruiting

  ADO-5030 in Bronchoconstriction Challenge, Phase 1b

  NCT07281274· Phase 1· Adovate· Source

• Recruiting

  Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations

  NCT07185997· Phase 3· ArriVent BioPharma, Inc.· Source

• Recruiting

  Resilience Enhancement Following Sleep Treatment

  NCT07298941· Phase 2· University of Virginia· Source

• Recruiting

  A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer

  NCT07276399· Phase 3· Janssen Research & Development, LLC· Source

• Recruiting

  Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer

  NCT07166094· Phase 3· Genmab· Source

• Recruiting

  Epicardial Adipose Tissue Composition and Heart Failure With Preserved Ejection Fraction

  NCT07178145· Phase 4· University of Virginia· Source

• Recruiting

  A Study of a Test for Postpartum Depression at Home

  NCT07186309· University of Virginia· Source

• Recruiting

  A Study of Dupilumab in Small Children With an Allergic Condition of the Esophagus (Food Pipe): Eosinophilic Esophagitis

  NCT07112378· Phase 3· Regeneron Pharmaceuticals· Source

• Active, not recruiting

  Randomized Controlled Study Evaluating Genicular Artery Embolization Against Intra-Articular Corticosteroid Knee Injection for Osteoarthritic Knee Pain

  NCT06872567· North American Science Associates Ltd.· Source

• Recruiting

  This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.

  NCT07028853· Phase 3· Pfizer· Source

• Recruiting

  Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

  NCT07007312· Phase 3· Kura Oncology, Inc.· Source

• Recruiting

  A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation

  NCT06859424· Phase 2· Center for International Blood and Marrow Transplant Research· Source

• Recruiting

  Zanzalintinib for the Treatment of Advanced Thyroid Cancer Before Surgery

  NCT06959511· Phase 2· M.D. Anderson Cancer Center· Source

• Recruiting

  Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors

  NCT06943755· Phase 2/3· Exelixis· Source

Showing 50 of 225.

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Head and neck cancer8 recruiting
• Lung cancer8 recruiting
• Acute myeloid leukaemia7 recruiting
• Colorectal cancer7 recruiting
• Stroke7 recruiting
• Endometrial cancer6 recruiting
• Prostate cancer6 recruiting
• Coronary artery disease5 recruiting
• Heart failure5 recruiting
• Obesity5 recruiting
• Pancreatic cancer5 recruiting
• Type 1 diabetes5 recruiting
• Childhood cancers4 recruiting
• Cystic fibrosis4 recruiting
• High blood pressure4 recruiting
• Liver and biliary tract cancer4 recruiting
• Myelodysplastic syndromes4 recruiting
• Ovarian cancer4 recruiting
• Acute lymphoblastic leukaemia3 recruiting
• Cervical cancer3 recruiting
• COPD3 recruiting
• Hypertrophic cardiomyopathy3 recruiting
• Insomnia3 recruiting
• Melanoma3 recruiting
• Mild cognitive impairment3 recruiting
• Multiple myeloma3 recruiting
• Myeloproliferative neoplasms3 recruiting
• Parkinson disease3 recruiting
• Smoking and nicotine dependence3 recruiting
• Triple-negative breast cancer3 recruiting
• Alzheimer disease2 recruiting
• Asthma2 recruiting
• Autism2 recruiting
• Bladder cancer2 recruiting
• Chronic kidney disease2 recruiting
• Chronic lymphocytic leukaemia2 recruiting
• Chronic myeloid leukaemia2 recruiting
• Diffuse large B-cell lymphoma2 recruiting
• Epilepsy2 recruiting
• Gastric and oesophageal cancer2 recruiting
• Glioblastoma2 recruiting
• Idiopathic pulmonary fibrosis2 recruiting
• Mantle cell lymphoma2 recruiting
• Myocarditis2 recruiting
• Osteoarthritis2 recruiting
• Postpartum depression2 recruiting
• Pulmonary arterial hypertension2 recruiting
• Type 2 diabetes2 recruiting
• ADHD1 recruiting
• Alcohol use disorder1 recruiting
• ANCA-associated vasculitis1 recruiting
• Aplastic anaemia1 recruiting
• Atrial fibrillation1 recruiting
• Brain aneurysm1 recruiting
• Charcot-Marie-Tooth disease1 recruiting
• Chronic rhinosinusitis with nasal polyps1 recruiting
• CIDP (chronic inflammatory demyelinating polyneuropathy)1 recruiting
• Crohn's disease1 recruiting
• Duchenne muscular dystrophy1 recruiting
• Eosinophilic oesophagitis1 recruiting
• Essential tremor1 recruiting
• Fatty liver disease (MASLD/MASH)1 recruiting
• Female infertility1 recruiting
• Follicular lymphoma1 recruiting
• Gestational diabetes1 recruiting
• Glaucoma1 recruiting
• Haemophilia1 recruiting
• Hodgkin lymphoma1 recruiting
• Huntington's disease1 recruiting
• Male hypogonadism (low testosterone)1 recruiting
• Mesothelioma1 recruiting
• Metastatic breast cancer1 recruiting
• Multiple sclerosis1 recruiting
• Neuroendocrine tumours1 recruiting
• Optic neuritis1 recruiting
• Osteonecrosis (avascular necrosis)1 recruiting
• Peripheral artery disease1 recruiting
• Polycystic ovary syndrome1 recruiting
• Sarcoma1 recruiting
• Sjögren's disease1 recruiting
• Spinal muscular atrophy1 recruiting
• Testicular cancer1 recruiting
• Thyroid cancer1 recruiting
• Ulcerative colitis1 recruiting
• Vascular dementia1 recruiting

Closed trials

• Terminated

  A Study to Assess CLBR001+ABBV-461 in Subjects With Locally Advanced or Metastatic Breast Cancer

  NCT06878248· Phase 1· Calibr, a division of Scripps Research· Source

• Completed

  Pilot Study of IC14 (Atibuclimab), an Anti-CD14 Monoclonal Antibody, to Treat STEMI

  NCT06678074· Phase 1/2· Implicit Bioscience· Source

• Completed

  Automated Insulin Delivery for Inpatients With Dysglycemia

  NCT06418880· Phase 3· Emory University· Source

• Completed

  Safety and Feasibility Testing of a Smaller Network Version of AIDANET

  NCT06633965· Marc Breton· Source

• Completed

  Investigating the Cholinergic Contribution to Gait Dysfunction in Parkinson's Disease

  NCT06903910· Phase 2· University of Virginia· Source

• Completed

  IC14 for Treatment of Acute Decompensated Heart Failure

  NCT06556810· Phase 1/2· Implicit Bioscience· Source

• Completed

  Evaluating the Anticancer Learning Circle Lifestyle Program in Endometrial Cancer Survivors

  NCT06550791· University of Virginia· Source

• Terminated

  Ropidoxuridine as a Radiosensitizer in Newly Diagnosed IDH-Wildtype Glioblastoma With Unmethylated MGMT Promoter

  NCT06359379· Phase 2· Shuttle Pharmaceuticals, Inc.· Source

• Completed

  EchoTip AcuCore Post-Market Clinical Study

  NCT06358001· Cook Research Incorporated· Source

• Withdrawn

  Exercise Training Study Before Bariatric Surgery

  NCT06274606· University of Virginia· Source

• Completed

  The PROTEMBO Trial

  NCT05873816· Protembis GmbH· Source

• Completed

  Collagen-targeted Positron Emission Tomography (PET) Imaging for Assessment of EGCG Effect

  NCT06265532· Phase 1· Hal Chapman· Source

• Completed

  The Effect and Safety of a Novel CGM-Based Titration Algorithm for Basal Insulin in T2DM Participants.

  NCT06111508· University of Virginia· Source

• Completed

  The Pediatric Artificial Pancreas Automated Initialization Trial

  NCT06017089· Marc Breton· Source

• Completed

  Epithelium-On Corneal Cross-linking in Subjects 8 to 45 Years of Age With Keratoconus

  NCT06100939· Phase 3· Epion Therapeutics· Source

• Completed

  ELUCIDATE FFRct Study

  NCT06018194· Elucid Bioimaging Inc.· Source

• Completed

  Study of Oral Epigallocatechin-3-gallate (EGCG) in IPF Patients

  NCT05195918· Phase 1· Hal Chapman· Source

• Recruiting

  Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure

  NCT05677100· Procyrion· Source

• Completed

  Pulmonary Hypertension Screening in Patients With Interstitial Lung Disease for Earlier Detection

  NCT05776225· United Therapeutics· Source

• Completed

  Mechanisms of Smell Improvement With Dupilumab.

  NCT05964465· Phase 4· Medical University of South Carolina· Source

• Completed

  RECOVER-VITAL: Platform Protocol to Measure the Effects of Antiviral Therapies on Long COVID Symptoms

  NCT05595369· Phase 2· Kanecia Obie Zimmerman· Source

• Completed

  A Study to Investigate Behavioral and Other Co-Occurring Outcomes With Epidiolex as Add-On Therapy in Participants Aged 1 to 65 Years of Age With Tuberous Sclerosis Complex

  NCT05864846· Phase 4· Jazz Pharmaceuticals· Source

• Completed

  Prevention of Cardiovascular Disease and Mortality in Patients With Psoriasis or Psoriatic Arthritis

  NCT05908240· University of Pennsylvania· Source

• Completed

  Effect of Dapagliflozin on Microvascular Function in Women With Symptoms of Coronary Artery Disease

  NCT05762952· Phase 1· University of Virginia· Source

• Completed

  A Randomized Trial Evaluating Control-IQ+ Technology in Adults With Type 2 Diabetes

  NCT05785832· Tandem Diabetes Care, Inc.· Source

• Completed

  A Study to Test How New Long-acting Insulin (Insulin Icodec) Works in the Body of Children and Teenagers

  NCT05790681· Phase 1· Novo Nordisk A/S· Source

• Completed

  Study of Onvansertib in Combination With FOLFIRI and Bevacizumab Versus FOLFIRI and Bevacizumab for Second Line Treatment of Metastatic Colorectal Cancer in Participants With a Kirsten Rat Sarcoma Virus Gene (KRAS) or Neuroblastoma-RAS (NRAS) Mutation

  NCT05593328· Phase 2· Cardiff Oncology· Source

• Completed

  Use of Control-IQ Technology 2.0 in Adults, Children, and Preschoolers With Type 1 Diabetes

  NCT05683392· Tandem Diabetes Care, Inc.· Source

• Terminated

  Clinical Utility of FES F18 PET/CT in Metastatic Breast Cancer Patients

  NCT05068726· GE Healthcare· Source

• Completed

  A Study to Evaluate Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis

  NCT05601882· Phase 3· AbbVie· Source

• Completed

  Abbott i-STAT High Sensitivity Troponin I Study

  NCT05629572· Abbott Point of Care· Source

• Recruiting

  A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma

  NCT05552222· Phase 3· Janssen Research & Development, LLC· Source

• Recruiting

  Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission

  NCT05230173· Mayo Clinic· Source

• Completed

  A Phase 1b/2 Trial of the Safety and Microbiological Activity of Bacteriophage Therapy in Cystic Fibrosis Subjects Colonized With Pseudomonas Aeruginosa

  NCT05453578· Phase 1/2· National Institute of Allergy and Infectious Diseases (NIAID)· Source

• Terminated

  Sacral Fracture Fusion/Fixation for Rapid Rehabilitation

  NCT05426356· SI-BONE, Inc.· Source

• Completed

  Trial of Centanafadine Efficacy and Safety as Monotherapy or as Adjunct to SSRI in Adults With Major Depressive Disorder

  NCT05536414· Phase 2· Otsuka Pharmaceutical Development & Commercialization, Inc.· Source

• Completed

  Pharmacokinetics Study of Oral 2-Deoxy-D-Glucose (2DG) in Subjects With a Confirmed Diagnosis of Epilepsy

  NCT05605301· Phase 2· University of Virginia· Source

• Withdrawn

  ENACT: A Study of ENX-101 as Adjunctive Treatment in Patients With Focal Seizures

  NCT05481905· Phase 2· Engrail Therapeutics INC· Source

• Completed

  Omnipod 5 System Compared to Pump Therapy

  NCT05409131· Insulet Corporation· Source

• Completed

  International Registry of Acute Kidney Injury in Cirrhosis: The GLOBAL AKI Project

  NCT05387811· Azienda Ospedaliera di Padova· Source

• Completed

  Placebo-controlled, Proof-of-concept Study to Evaluate the Safety and Efficacy of Lanifibranor Alone and in Combination With SGLT2 Inhibitor EmpaGliflozin in patiEnts With NASH and Type 2 Diabetes Mellitus

  NCT05232071· Phase 2· Inventiva Pharma· Source

• Completed

  A Study of Aticaprant as Adjunctive Therapy in Adult Participants With Major Depressive Disorder (MDD) With Moderate-to-severe Anhedonia and Inadequate Response to Current Antidepressant Therapy

  NCT05455684· Phase 3· Janssen Research & Development, LLC· Source

• Terminated

  Study of Posoleucel (ALVR105,Viralym-M) for Multi-Virus Prevention in Patients Post-Allogeneic Hematopoietic Cell Transplant

  NCT05305040· Phase 2/3· AlloVir· Source

• Completed

  CBT-I or Zolpidem/Trazodone for Insomnia

  NCT04468776· Phase 4· California Pacific Medical Center Research Institute· Source

• Completed

  A Study of Azenosertib (ZN-c3) and Niraparib in Subjects With Platinum-Resistant Ovarian Cancer

  NCT05198804· Phase 1/2· K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc· Source

• Completed

  Study to Evaluate the Safety, Tolerability, PDs, and Efficacy of CNP-104 in Subjects With Primary Biliary Cholangitis

  NCT05104853· Phase 1/2· COUR Pharmaceutical Development Company, Inc.· Source

• Completed

  Upfront Chimeric Antigen Receptor T-Cell to Upgrade Response in Multiple Myeloma

  NCT05032820· Phase 2· Medical College of Wisconsin· Source

• Completed

  Establishing the Effectiveness of Publicly Available Smoking Cessation Resource

  NCT05055778· University of Virginia· Source

• Completed

  Multilevel HPV Self-Testing Intervention for the Increase of Cervical Cancer Screening Among Women in Appalachia

  NCT04411849· Ohio State University Comprehensive Cancer Center· Source

• Withdrawn

  Relative Desirability of Metformin vs. Birth Control Pill in Treating PCOS in Women of Later Reproductive Age

  NCT03905941· Early phase 1· University of Virginia· Source

Showing 50 of 108.

Conditions

Diseases this institution publishes on or runs trials for.

• Stroke153 works · 9 trials
• Obesity106 works · 9 trials
• Heart failure97 works · 13 trials
• Alzheimer disease94 works · 4 trials
• Epilepsy71 works · 8 trials
• Melanoma61 works · 7 trials
• Type 1 diabetes54 works · 13 trials
• Coronary artery disease53 works · 14 trials
• Prostate cancer50 works · 12 trials
• Glioblastoma46 works · 5 trials
• Osteoarthritis40 works · 5 trials
• Cystic fibrosis35 works · 8 trials
• Idiopathic pulmonary fibrosis32 works · 5 trials
• Insomnia27 works · 4 trials
• Autism27 works · 4 trials
• Kidney cancer25 works · 1 trial
• Brain metastases24 works · 0 trials
• Cervical cancer24 works · 7 trials
• Endometrial cancer20 works · 10 trials
• Hypertrophic cardiomyopathy17 works · 5 trials
• Sickle cell disease15 works · 1 trial
• Myocarditis15 works · 2 trials
• Hydrocephalus15 works · 0 trials
• Pituitary tumours14 works · 0 trials
• Cerebral palsy14 works · 0 trials
• ALS (motor neurone disease)13 works · 1 trial
• Eosinophilic oesophagitis13 works · 2 trials
• Aortic aneurysm12 works · 2 trials
• Sarcoidosis12 works · 0 trials
• Hypothyroidism12 works · 0 trials